Psilocybin therapy for females with anorexia nervosa: a phase 1, open-label feasibility study

Anorexia nervosa (AN) is a deadly illness with no proven treatments to reverse core symptoms and no medications approved by the US Food and Drug Administration. Novel treatments are urgently needed to improve clinical outcomes. In this open-label feasibility study, 10 adult female participants (mean...

Descripción completa

Detalles Bibliográficos
Autores principales: Peck, Stephanie Knatz, Shao, Samantha, Gruen, Tessa, Yang, Kevin, Babakanian, Alexandra, Trim, Julie, Finn, Daphna M., Kaye, Walter H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427429/
https://www.ncbi.nlm.nih.gov/pubmed/37488291
http://dx.doi.org/10.1038/s41591-023-02455-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427429/
https://www.ncbi.nlm.nih.gov/pubmed/37488291
http://dx.doi.org/10.1038/s41591-023-02455-9

Ejemplares similares